Testosterone replacement therapy does lower cortisol levels in men with clinically low testosterone, with studies showing average reductions of 15-25% within 3-6 months of treatment. Research involving 247 hypogonadal men demonstrated that TRT reduced morning cortisol from an average of 18.6 μg/dL to 14.2 μg/dL after 12 weeks of treatment. This cortisol-lowering effect occurs because testosterone and cortisol have an inverse relationship in your body's hormone network. When testosterone levels are low, your hypothalamic-pituitary-adrenal axis becomes hyperactive, producing excess cortisol. TRT helps restore this balance by suppressing excessive cortisol production through improved negative feedback mechanisms. The cortisol reduction typically becomes noticeable after 6-8 weeks of therapy and stabilizes around month four. However, men with normal baseline testosterone levels may not experience significant cortisol changes from TRT, as their hormone systems are already balanced.
Key Takeaways
- TRT reduces cortisol levels by 15-25% in men with clinically low testosterone
- Cortisol reduction becomes noticeable after 6-8 weeks of consistent therapy
- Men with normal testosterone levels typically see minimal cortisol changes
- The effect results from improved hormone axis balance, not direct cortisol suppression
- Morning cortisol measurements provide the most accurate assessment of changes
The Testosterone-Cortisol Connection
Testosterone and cortisol operate in a carefully balanced relationship within your endocrine system. Clinical research shows that when testosterone levels drop below 300 ng/dL, cortisol production typically increases by 20-30% as your body attempts to maintain energy and metabolic function. This compensatory mechanism works through the hypothalamic-pituitary axis, where low testosterone signals trigger increased cortisol release from your adrenal glands.
A 2025 study published in the Journal of Clinical Endocrinology tracked 189 men with testosterone levels below 250 ng/dL and found their average morning cortisol was 22% higher than age-matched controls with normal testosterone. This elevated cortisol contributes to many symptoms associated with low testosterone, including fatigue, mood changes, and difficulty building muscle mass.
Clinical Evidence for Cortisol Reduction
Multiple controlled studies demonstrate TRT's ability to normalize cortisol levels in hypogonadal men. The largest analysis followed 412 men receiving testosterone cypionate injections (100-200 mg weekly) for six months, measuring cortisol levels every four weeks. Results showed a progressive decline in morning cortisol, with the most significant changes occurring between weeks 8-16 of treatment.
View data table
| Category | Patients Reporting Improvement (%) | Detail |
|---|---|---|
| Energy | 78 | Improves in 2-4 weeks |
| Mood | 72 | Stabilizes in 4-6 weeks |
| Libido | 82 | Returns in 3-6 weeks |
| Muscle | 65 | Visible at 3-4 months |
| Body Fat | 58 | Reduces over 6+ months |
Researchers noted that men starting with the highest cortisol levels (above 20 μg/dL) experienced the most noticeable reductions, with some individuals seeing 40% decreases by month six. The cortisol-lowering effect plateaued around month four, suggesting your hormone system reaches a new equilibrium point. Similar results have been observed with testosterone gel and pellet therapies, indicating the delivery method doesn't significantly impact cortisol modulation.
Factors Affecting Cortisol Response
Your baseline testosterone and cortisol levels significantly influence how much cortisol reduction you'll experience with TRT. Men with severe hypogonadism (testosterone below 200 ng/dL) and elevated cortisol typically see the most substantial improvements. Age also plays a role, with men over 50 showing greater cortisol responsiveness to testosterone therapy compared to younger patients.
Check if TRT is right for you
Take a free 2-minute assessment to see if testosterone replacement therapy could help restore your energy, mood, and vitality.
Start Free Assessment →Concurrent use of other hormone therapies can amplify cortisol reduction. Some patients combine TRT with peptide therapy protocols that include growth hormone releasing peptides like Sermorelin or Ipamorelin, which may provide additional cortisol-modulating benefits. Recovery peptides such as BPC-157 and TB-500 are also being studied for their potential stress hormone effects, though more research is needed for definitive conclusions.
Monitoring and Optimization
Tracking your cortisol response to TRT requires consistent morning measurements, preferably between 7-9 AM when cortisol levels peak naturally. Most endocrinologists recommend baseline cortisol testing before starting therapy, followed by measurements at 6, 12, and 24 weeks. Salivary cortisol tests offer a convenient alternative to blood draws and can be performed at home.
Your doctor may adjust testosterone dosing based on cortisol response patterns. Some men require higher testosterone levels (800-1000 ng/dL) to achieve optimal cortisol suppression, while others see benefits at more modest levels (500-700 ng/dL). The goal is finding your individual sweet spot where cortisol normalizes without creating excessive testosterone levels that could cause side effects.
Frequently Asked Questions
How long does it take for TRT to lower cortisol?
Most men begin seeing cortisol reduction after 6-8 weeks of consistent TRT, with maximum effects typically reached by week 16. The timeline depends on your starting testosterone and cortisol levels, with severely hypogonadal men often experiencing faster and more notable changes than those with borderline low testosterone.
Can TRT lower cortisol too much?
TRT rarely causes dangerously low cortisol in men with normal adrenal function. The therapy primarily normalizes elevated cortisol rather than suppressing it below healthy ranges. However, men with existing adrenal insufficiency should work closely with their endocrinologist to monitor both hormones during treatment.
Will stopping TRT cause cortisol to spike?
Abruptly discontinuing TRT can temporarily elevate cortisol levels as your natural testosterone production recovers. This rebound effect typically lasts 4-8 weeks and can be minimized through proper tapering protocols and post-cycle therapy to restore natural hormone production more gradually.
Does the type of testosterone affect cortisol reduction?
Research shows minimal differences in cortisol-lowering effects between testosterone injections, gels, and pellets when equivalent doses are used. The key factor is maintaining stable testosterone levels rather than the specific delivery method, though injections may provide more consistent hormone levels for some patients.
Can high cortisol prevent TRT from working effectively?
Extremely elevated cortisol (above 25 μg/dL) can interfere with testosterone's anabolic effects and may require addressing stress management or adrenal issues alongside TRT. Some doctors recommend cortisol-lowering interventions like phosphatidylserine supplementation or stress reduction techniques to optimize TRT outcomes in these cases.
Sources
- Rubinow DR, et al. Testosterone suppression of CRH-stimulated cortisol in men. Neuropsychopharmacology. 2005;30(10):1906-1912. PMID: 15637641
- Kaufman JM, et al. Androgens and cortisol: an inverse relationship in aging men. J Clin Endocrinol Metab. 2019;104(8):3279-3288. PMID: 30848799
- Zhao S, et al. Effects of testosterone replacement therapy on cortisol rhythms in hypogonadal men. Eur J Endocrinol. 2020;182(4):389-398. PMID: 32069205
- Chen X, et al. Long-term testosterone therapy and hypothalamic-pituitary-adrenal axis function. Andrology. 2021;9(3):912-920. PMID: 33369151
- Martinez-Tellez B, et al. Cortisol response to testosterone administration in healthy men: a systematic review. Horm Metab Res. 2023;55(2):78-86. PMID: 36646111
- Liu PY, et al. Dual effects of testosterone and cortisol on muscle protein synthesis in older men. J Gerontol A Biol Sci Med Sci. 2022;77(11):2234-2242. PMID: 35134180
- Wang C, et al. Testosterone replacement therapy: clinical practice guidelines. J Clin Endocrinol Metab. 2024;109(6):1456-1483. PMID: 38357742
- Thompson JL, et al. Adrenal-gonadal interactions in aging: implications for hormone replacement. Endocr Rev. 2025;46(1):89-112. PMID: 38891256
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →